Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 145Kidney Neoplasms 42Neoplasms 39Neoplasm Metastasis 35Breast Neoplasms 33Gastrointestinal Stromal Tumors 31Carcinoma, Non-Small-Cell Lung 22Prostatic Neoplasms 16Urinary Bladder Neoplasms 13Colorectal Neoplasms 12Brain Neoplasms 12Pancreatic Neoplasms 11Glioblastoma 11Carcinoma, Hepatocellular 11Melanoma 10Lung Neoplasms 10Carcinoma 10Stomach Neoplasms 8Neuroendocrine Tumors 8Thyroid Neoplasms 7Sarcoma 7Ovarian Neoplasms 7Multiple Myeloma 7Liver Neoplasms 7Adenoma, Islet Cell 7Small Cell Lung Carcinoma 6Leukemia, Myeloid, Acute 6Glioma 6Esophageal Neoplasms 6Clear-cell metastatic renal cell carcinoma 6

Interventions

Microscopy, Confocal 2Indocyanine Green 2Everolimus 2Dermoscopy 2varlilumab 1Ultrasonography 1Tumor Burden 1Sunitinib 1Simvastatin 1Radiosurgery 1Palliative Care 1Observation 1Neoadjuvant Therapy 1Narrow Band Imaging 1Mastectomy, Segmental 1Interferon alpha-2 1IFL protocol 1Gastrectomy 1Folfox protocol 1Esophagectomy 1Endoscopic Mucosal Resection 1Drug Delivery Systems 1Drug Combinations 1Chemoradiotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Margins of Excision × Sunitinib × Clear all
NCT01784978 2017-10-02

SUNRISES

Associació per a la Recerca Oncologica, Spain

Phase 2 Terminated
41 enrolled
Genitourinary

Margins of Excision, Carcinoma, Renal Cell, Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡